Wait, we have a special offer for you! ✋

Get your exclusive discount now

Use FY25SAVE to get flat 20% off on the report No, I'd pay the full price

Terms & Conditions : This coupon is vaild exclusively for Global Market Reports 2025 and can be used Until March 31 , 2025 .

Global Tresiba Market Report 2025

Tresiba Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Diabetes Type 1, Diabetes Type 2), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies), By End User (Adults, Geriatric Patients, Pediatric Patients)

Tresiba Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Tresiba Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

What Is Covered Under Tresiba Market?

Tresiba (insulin degludec) is a long-acting insulin used to manage diabetes mellitus in adults and children. It helps to control blood sugar levels in individuals with type 1 or type 2 diabetes by providing a steady release of insulin over a prolonged period.

The main indication in the tresiba market are diabetes type 1 and diabetes type 2. Type 1 diabetes refers to a chronic autoimmune condition where the immune system mistakenly destroys insulin-producing beta cells in the pancreas, leading to insufficient insulin production and elevated blood sugar levels. The various distribution channels include hospital pharmacies, retail pharmacies, specialty pharmacies, and online pharmacies and, several end users encompass adults, geriatric patients, and pediatric patients.

What Is The Tresiba Market Size 2025 And Growth Rate?

The tresiba market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increase in diabetes prevalence, growth in demand for long-acting insulin analogs, rise in awareness of diabetes management, rise in regulatory approvals, and improved patient adherence due to reduced injection frequency.

What Is The Tresiba Market Growth Forecast?

The tresiba market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing prevalence of diabetes globally, rising adoption of long-acting insulin analogs, supportive government reimbursement policies, growing awareness of personalized diabetes treatment plans, expansion of healthcare infrastructure, and increasing research and development. Major trends in the forecast period include adoption of personalized dosing algorithms, advancements in insulin delivery devices, integration with continuous glucose monitoring (CGM) systems, development of biosimilar insulin options, and innovations in ultra-long-acting insulin formulations.

Tresiba Market Size and growth rate 2025 to 2029: Graph

How Is The Tresiba Market Segmented?

The tresiba market covered in this report is segmented –

1) By Indication: Diabetes Type 1; Diabetes Type 2

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Specialty Pharmacies; Online Pharmacies

3) By End User: Adults; Geriatric Patients; Pediatric Patients

Book your 30 minutes free consultation with our research experts

Contact Us

What Is Driving The Tresiba Market? Rising Prevalence Of Diabetes Driving Demand For Advanced Insulin Therapies

The increase in the prevalence of diabetes is expected to propel the growth of the tresiba market going forward. Diabetes is a chronic medical condition when the body cannot properly regulate blood sugar (glucose) levels. The increasing prevalence of diabetes is attributed to factors such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, aging populations, and genetic predisposition. Tresiba is beneficial for addressing diabetes by providing patients with better glycemic control, reducing the risk of hypoglycemia, and offering flexible dosing options, which enhance treatment adherence and improve overall diabetes management outcomes. For instance, in June 2023, according to the Institute for Health Metrics and Evaluation, a US-based public health research institute, over half a billion people globally are living with diabetes in 2023. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the increase in the prevalence of diabetes is driving the growth of the tresiba market.

What Is Driving The Tresiba Market? Rising Obesity Rates Driving Demand For Effective Insulin Therapies

The rise in obesity is expected to propel the growth of the tresiba market going forward. Obesity is a medical condition characterized by excessive body fat that can negatively impact a person’s health. It is typically determined by measuring body mass index (BMI), a ratio of a person's weight to height. The rising prevalence of obesity is attributed to shifts in global food systems and eating habits, characterized by increased consumption of ultra-processed foods, sedentary lifestyles, and economic factors that make unhealthy food choices more readily available. Tresiba helps obese patients by providing long-acting insulin that aids in better glycemic control, reducing the risk of hypoglycemia, and supporting weight management through flexible dosing options. For instance, in 2024, according to the Office for Health Improvement and Disparities, a UK-based government department, between 2022 and 2023, around 64.0% of adults aged 18 and older in England were classified as overweight or obese, an increase from 63.8% in 2021 to 2022. Therefore, the rise in obesity is driving the growth of the tresiba market.

Who Are The Major Players In The Global Tresiba Market?

Major companies operating in the tresiba market are Novo Nordisk A/S

What Are The Key Trends Of The Global Tresiba Market? Development Of Unbranded Biologics Enhances Affordability And Access To Insulin Therapy

The key trend in the tresiba market is the development of unbranded biologics to provide more affordable alternatives to branded medications by expanding access to insulin therapy while maintaining patient efficacy and safety, particularly in cost-sensitive markets. Unbranded biologics refer to biological medicines identical to their branded counterparts in molecular composition, quality, safety, and efficacy but are marketed without a specific brand name. For instance, in September 2022, Novo Nordisk A/S, a Denmark-based pharmaceutical company, announced the launch of its Food and Drug Administration (FDA)-approved unbranded biologic version of Tresiba (insulin degludec), a long-acting basal insulin designed to manage high blood sugar in patients aged one and older with diabetes. It is set to be available for prescription, the unbranded version aims to enhance affordability, particularly for uninsured and underinsured patients, as part of efforts to provide more accessible insulin options.

Regional Analysis For The Global Tresiba Market

North America was the largest region in the tresiba market in 2024. The regions covered in the tresiba market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tresiba market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Tresiba Market?

The tresiba market consists of sales of tresiba U-100, tresiba U-200, and pre-filled flextouch pen. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tresiba Industry?

The tresiba market research report is one of a series of new reports from The Business Research Company that provides tresiba market statistics, including the tresiba industry's global market size, regional shares, competitors with a tresiba market share, detailed tresiba market segments, market trends and opportunities, and any further data you may need to thrive in the tresiba industry. This tresiba market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Tresiba Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The tresiba market covered in this report is segmented –
1) By Indication: Diabetes Type 1; Diabetes Type 2
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Specialty Pharmacies; Online Pharmacies
3) By End User: Adults; Geriatric Patients; Pediatric Patients
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Novo Nordisk A/S
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Tresiba Market Characteristics

    3. Tresiba Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Tresiba Market Trends And Strategies

    5. Tresiba Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Tresiba Growth Analysis And Strategic Analysis Framework

    6.1. Global Tresiba PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Tresiba Market Growth Rate Analysis

    6.4. Global Tresiba Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Tresiba Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Tresiba Total Addressable Market (TAM)

    7. Global Tresiba Pricing Analysis & Forecasts

    8. Tresiba Market Segmentation

    8.1. Global Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Diabetes Type 1

    Diabetes Type 2

    8.2. Global Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospital Pharmacies

    Retail Pharmacies

    Specialty Pharmacies

    Online Pharmacies

    8.3. Global Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adults

    Geriatric Patients

    Pediatric Patients

    9. Global Tresiba Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Tresiba Market Regional And Country Analysis

    10.1. Global Tresiba Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Tresiba Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Tresiba Market

    11.1. Asia-Pacific Tresiba Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Tresiba Market

    12.1. China Tresiba Market Overview

    12.2. China Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Tresiba Market

    13.1. India Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Tresiba Market

    14.1. Japan Tresiba Market Overview

    14.2. Japan Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Tresiba Market

    15.1. Australia Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Tresiba Market

    16.1. South Korea Tresiba Market Overview

    16.2. South Korea Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Tresiba Market

    17.1. Western Europe Tresiba Market Overview

    17.2. Western Europe Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Tresiba Market

    18.1. UK Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Tresiba Market

    19.1. Germany Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Tresiba Market

    20.1. France Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Tresiba Market

    21.1. Eastern Europe Tresiba Market Overview

    21.2. Eastern Europe Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Tresiba Market

    22.1. North America Tresiba Market Overview

    22.2. North America Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Tresiba Market

    23.1. USA Tresiba Market Overview

    23.2. USA Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Tresiba Market

    24.1. Canada Tresiba Market Overview

    24.2. Canada Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Tresiba Market

    25.1. South America Tresiba Market Overview

    25.2. South America Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Tresiba Market

    26.1. Middle East Tresiba Market Overview

    26.2. Middle East Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Tresiba Market

    27.1. Africa Tresiba Market Overview

    27.2. Africa Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Tresiba Market Competitive Landscape And Company Profiles

    28.1. Tresiba Market Competitive Landscape

    28.2. Tresiba Market Company Profiles

    28.2.1. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

    29. Global Tresiba Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Tresiba Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Tresiba Market

    32. Recent Developments In The Tresiba Market

    33. Tresiba Market High Potential Countries, Segments and Strategies

    33.1 Tresiba Market In 2029 - Countries Offering Most New Opportunities

    33.2 Tresiba Market In 2029 - Segments Offering Most New Opportunities

    33.3 Tresiba Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Tresiba Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Tresiba Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Novo Nordisk A/S Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Tresiba Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Tresiba Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Tresiba Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Tresiba Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Tresiba Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Novo Nordisk A/S Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hematology drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Drug Delivery Devices Market 2021 - By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Pet Diabetes Care Global Market Report 2025 – By Drug Type( Insulin Therapy, Oral Medication ), By Device Type( Glucose Monitoring Devices, Insulin Delivery Devices ), By Animal Type( Canine, Feline, Other Animal Types ), By End-User( Veterinary Clinics, Home Care Settings, Veterinary Hospitals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Digital Diabetes Management Global Market Report 2025 – By Product & Service (Devices, Application, Data Management Software & Platforms, Services), By Device Type (Handheld Devices, Wearable Devices), By End User (Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diabetes Care Devices Global Market Report 2025 – By Type (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meter), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By Type Of Testing (Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diabetes Care Devices Market 2022 - By Type (Blood Glucose Test Strips, Lancing Devices, Continuous Glucose Monitoring Devices, Insulin Pens, Syringes, Pumps And Injectors), By Type Of Expenditure (Public, Private), By End Use (Hospitals And Clinics, Diagnostic Centers), By Product (Disposables, Instruments/Equipment), By Type Of Testing (Point Of Care Testing, Non-Point Of Care Testing), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Ambulatory IV Infusion Pumps Market 2022 - By Therapy (Infusion Pumps, Anti-Infective Infusion Pump), By Patient Care Settings (Hospitals, Home Healthcare), By Application (Chemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Anti-Infective), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Diabetes Therapies Market - By Type (Injectables, Oral) And By Region, Opportunities And Strategies - Global Forecast To 2023

View Report

Smart Insulin Pens Market 2021 - By Type (First Generation Pens, Second Generation Pens (Bluetooth Enabled, USB Connected)), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings), By Usability (Prefilled, Reusable), By Application (Type 1 Diabetes, Type 2 Diabetes), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Tresiba market?

Tresiba (insulin degludec) is a long-acting insulin used to manage diabetes mellitus in adults and children. It helps to control blood sugar levels in individuals with type 1 or type 2 diabetes by providing a steady release of insulin over a prolonged period. For further insights on the Tresiba market, request a sample here

How will the Tresiba market drivers and restraints affect the market dynamics? What forces will shape the Tresiba industry going forward?

The Tresiba market major growth driver - Rising Prevalence Of Diabetes Driving Demand For Advanced Insulin Therapies. For further insights on the Tresiba market, request a sample here

What is the forecast market size or the forecast market value of the Tresiba market?

The Tresiba market size has grown strongly in recent years. The tresiba market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increase in diabetes prevalence, growth in demand for long-acting insulin analogs, rise in awareness of diabetes management, rise in regulatory approvals, and improved patient adherence due to reduced injection frequency. The tresiba market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing prevalence of diabetes globally, rising adoption of long-acting insulin analogs, supportive government reimbursement policies, growing awareness of personalized diabetes treatment plans, expansion of healthcare infrastructure, and increasing research and development. Major trends in the forecast period include adoption of personalized dosing algorithms, advancements in insulin delivery devices, integration with continuous glucose monitoring (CGM) systems, development of biosimilar insulin options, and innovations in ultra-long-acting insulin formulations. For further insights on the Tresiba market, request a sample here

How is the Tresiba market segmented?

The tresiba market covered in this report is segmented –
1) By Indication: Diabetes Type 1; Diabetes Type 2
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Specialty Pharmacies; Online Pharmacies
3) By End User: Adults; Geriatric Patients; Pediatric Patients For further insights on the Tresiba market, request a sample here

Which region has the largest share of the Tresiba market? What are the other regions covered in the report?

North America was the largest region in the tresiba market in 2024. The regions covered in the tresiba market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Tresiba market, request a sample here.

Who are the major players in the Tresiba market?

Major companies operating in the tresiba market are Novo Nordisk A/S . For further insights on the Tresiba market, request a sample here.

What are the key trends in the Tresiba market?

Major trends in the Tresiba market include Development Of Unbranded Biologics Enhances Affordability And Access To Insulin Therapy. For further insights on the Tresiba market, request a sample here.

What are the major opportunities in the Tresiba market? What are the strategies for the Tresiba market?

For detailed insights on the major opportunities and strategies in the Tresiba market, request a sample here.

How does the Tresiba market relate to the overall economy and other similar markets?

For detailed insights on Tresiba's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Tresiba industry?

For detailed insights on the mergers and acquisitions in the Tresiba industry, request a sample here.

What are the key dynamics influencing the Tresiba market growth? SWOT analysis of the Tresiba market.

For detailed insights on the key dynamics influencing the Tresiba market growth and SWOT analysis of the Tresiba industry, request a sample here.